AS
CRL icon

Altshuler Shaham’s Charles River Laboratories CRL Stock Holding History

Altshuler Shaham’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-130
Closed -$54K – 563
2021
Q3 		$54K Sell
130
-13
-9% -$5.4K ﹤0.01% 399
2021
Q2 		$53K Buy
+143
New +$47.8K ﹤0.01% 433
2021
Q1 		– Sell
-154
Closed -$38K – 473
2020
Q4 		$38K Buy
154
+29
+23% +$6.91K ﹤0.01% 312
2020
Q3 		$28K Buy
+125
New +$25.9K ﹤0.01% 287
2020
Q2 		– Sell
-86
Closed -$11K – 393
2020
Q1 		$11K Buy
+86
New +$12.9K ﹤0.01% 284

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altshuler Shaham's CRL Position: Q4 2021 in Review

Altshuler Shaham sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 130 shares — an estimated $54K sold.

Altshuler Shaham first reported a position in CRL in Q1 2020 and held it in 5 quarters. The position peaked at $54K in Q3 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • Altshuler Shaham reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
  • Altshuler Shaham sold 130 Charles River Laboratories shares in Q4 2021, an estimated $54K.
  • Altshuler Shaham first reported a position in Charles River Laboratories in Q1 2020 and held it in 5 quarters.
  • Altshuler Shaham's Charles River Laboratories position peaked at $54K in Q3 2021.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Altshuler Shaham's 13F filing for Q4 2021, filed 15 Feb 2022.